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Objectives: Exercise induces changes in haemostatic parameters and core body temperature 2 
(CBT). We aimed to assess whether exercise-induced elevations in CBT induce pro-3 
thrombotic changes in a dose-dependent manner.  4 
Design: Observational study. 5 
Methods: CBT and haemostatic responses were measured in 62 participants of a 15-km road 6 
race at baseline and immediately after finishing. As haemostasis assays are routinely 7 
performed at 37°C, we corrected the assay temperature for the individual’s actual CBT at 8 
baseline and finish in a subgroup of n=25. 9 
Results: All subjects (44±11 years, 69% male) completed the race at a speed of 12.1±1.8 10 
km/h. CBT increased significantly from 37.6±0.4°C to 39.4±0.8°C (p<0.001). Post-exercise, 11 
haemostatic activity was increased, as expressed by accelerated thrombin generation and an 12 
attenuated plasmin response. Synchronizing assay temperature to the subjects’ actual CBT 13 
resulted in additional differences and stronger acceleration of thrombin generation 14 
parameters. 15 
Conclusions: This study demonstrates that exercise induces a prothrombotic state, which 16 
might be partially dependent on the magnitude of the exercise-induced CBT rise. 17 
Synchronizing the assay temperature to approximate the subject’s CBT is essential to obtain 18 
more accurate insight in the haemostatic balance during thermoregulatory challenging 19 
situations. Finally, this study shows that short-lasting exposure to a CBT of 41.2°C does not 20 
result in clinical symptoms of severe coagulation. We therefore hypothesize that prolonged 21 
exposure to a high CBT or an individual-specific CBT threshold needs to be exceeded before 22 
derailment of the haemostatic balance occurs. 23 
 24 




Strenuous exercise induces a hypercoagulable state, hallmarked by an increased factor VIII 2 
concentration and a subsequently increased (in vitro) thrombin generation1-3. The increased 3 
thrombin enables fibrin formation, which stabilizes the platelet plug4. Simultaneous to these 4 
prothrombotic changes, increased levels of tissue plasminogen activator and reduced levels 5 
of plasminogen activator inhibitor hallmark increased fibrinolysis1 3 4. In this manner, the 6 
prothrombotic effects of exercise are offset by increased fibrinolysis, which prevents the 7 
formation of excess blood clots. Whilst the magnitude of these haemostatic changes are 8 
generally well balanced during general aerobic exercise, they are associated with an 9 
increased risk of cardiovascular complications such as acute coronary syndrome in individuals 10 
with previous cardiovascular disease5. 11 
 12 
In addition to prothrombotic changes, exercise also leads to an increase in core body 13 
temperature (CBT)6 7. Whilst this exercise-induced CBT increase is a normal result of 14 
metabolic heat production8, excessive increases in CBT to values above 40°C can potentially 15 
result in heatstroke6 9 10. Heatstroke is characterized by neurological symptoms (delirium, 16 
coma) and a derailed haemostatic response that results in a disease state similar to diffuse 17 
intravascular coagulation9-11. Potential consequences of heatstroke are multi-organ failure, in 18 
part due to thrombotic complications, and may result in death9. Hence, strong CBT rises during 19 
exercise bear the risk of developing potential serious thrombotic complications. Conversely, 20 
hypothermia (a CBT <35°C) has been shown to negatively impact on haemostatic activity, 21 
resulting in an increased bleeding diathesis12 13. These observations suggest that CBT directly 22 
impacts on the activity of the haemostatic system, and the procoagulant responses during 23 
exercise could thus theoretically be partly caused by an increased CBT. However, whether an 24 
increased CBT during exercise actually induces prothrombotic changes in a dose-dependent 25 




Therefore, the first aim of this study was to investigate whether the exercise-induced elevation 1 
in CBT induces prothrombotic changes in a dose-dependent manner. To that end, we 2 
measured thermal and haemostatic responses in 62 participants of a 15-km road race at 3 
baseline and immediately after finishing.  4 
 5 
Interestingly, haemostatic assays are routinely performed at a temperature of 37°C, whilst the 6 
in vivo CBT in the present study population was expected to be substantially higher (≥ 39.0°C) 7 
at the finish line7. Routinely obtained haemostasis data might thus provide inaccurate 8 
information due to potentially changing properties of the clotting factors at elevated 9 
temperatures14-16. Therefore, as a second aim, we corrected the temperature at which the 10 
assay is performed to approximate the subjects’ actual CBT at baseline and after finishing in 11 
a subgroup of 25 individuals and investigated whether this leads to different results compared 12 
to the routine assessment at 37°C. We hypothesized that an increased CBT at the finish line 13 
would enhance prothrombotic responses, and that adjusting the temperature at which the 14 
haemostasis assay is performed to approximate the subjects’ actual CBT would show a more 15 
pronounced haemostatic activation. 16 
 17 
Methods 18 
Sixty-two individuals (43 males, 19 females; age 44±11 years; height 178±8 cm; body weight 19 
72.8±10.5 kg; body mass index 22.9±2.3 kg/m2) who participated in a 15-km road race (Seven 20 
Hills Run, Nijmegen, the Netherlands) were recruited for the present study. Recruitment took 21 
place identically as previously described by the present authors7. Before being included in the 22 
present study, all subjects provided a written informed consent and all subjects were screened 23 
for the presence of any exclusion criteria for using the temperature pill: 1. A history of 24 
obstructive or inflammatory bowel disease or prior abdominal surgery, 2. The presence of any 25 
implanted electric (medical) device, 3. A scheduled MRI scan within 1 week after the event, or 26 
4. Pregnancy. None of the subjects had a history of cardiovascular or thrombotic disease, 27 
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none of the subjects used any anticoagulant medication. The average training status of our 1 
subjects was 3.6±2.1 hours of running exercise per week for the past year. Study procedures 2 
were approved by the Radboud university medical center Ethics Committee and accorded to 3 
the principles of the declaration of Helsinki. 4 
 5 
Baseline measurements were performed 2 hours before the start of the race in a laboratory 6 
set up 50 meters from the start/finish line. CBT was measured at baseline, 1 minute before 7 
the start, and within 15-seconds after finishing. Venous blood samples were obtained via 8 
venipuncture from an antecubital vein at baseline and within 5 minutes after finishing. No 9 
measurements were performed during exercise, and subjects completed the race at a self-10 
selected pace. Body weight was measured at baseline and immediately after finishing (Seca 11 
888, Hamburg, Germany), and relative changes in body weight were calculated to determine 12 
the hydration status of participants. Dehydration was defined as a body weight loss ≥2%17. 13 
Subjects ingested an individually calibrated telemetric temperature pill at least five hours (8 14 
a.m.) before the race (start 1 p.m.) to prevent interaction of the CBT measurements with fluid 15 
ingestion during testing18. CBT was measured using a portable telemetry system (CorTemp™ 16 
system, HQ Inc., Palmetto, USA), which has been demonstrated to safely and reliably 17 
measure CBT19 20. The average of three consecutive measurements for each time point was 18 
used for further analyses.  19 
Based on finish CBT, subjects were classified as low- (CBT <39) moderate- (39≥ finish CBT 20 
<40) or high-responders (CBT ≥40). The exercise-induced increase in CBT (ΔCBT) was 21 
calculated by subtracting baseline CBT from finish CBT. Again, three subgroups were created 22 
to classify low- (ΔCBT < 1.5) moderate- (1.5≥ ΔCBT <2.5) and high-responders (ΔCBT ≥2.5). 23 
 24 
Venous blood samples were collected from an anticubital vein in CTAD (sodium citrate 25 
theophylline, adenosine dypyridamol) buffered collection tubes in our on-site laboratory. 26 
Samples were centrifuged at 4200 rpm for 15 minutes, after which the plasma was 27 
immediately transferred into new uncoated Eppendorf tubes which were subsequently snap 28 
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frozen in liquid nitrogen and stored at -80°C until further analysis. Thrombin and plasmin 1 
generation were simultaneously measured using the ‘Nijmegen Haemostasis Assay’21. This 2 
assay allows simultaneous measurement of in vitro thrombin and plasmin generation in the 3 
same blood specimen in a single well (Supplemental Figure 1). Lag time thrombin generation 4 
describes the lag time between activation of the coagulation cascade and the time at which 5 
the initiation of thrombin generation is measured. Time to thrombin peak refers to the time 6 
between activation of the coagulation cascade and reaching the peak thrombin generation 7 
value. Thrombin peak height refers to the maximal thrombin generation rate. The area under 8 
the curve reflects the total thrombin potential (AUCthrombin). Plasmin peak time refers to the time 9 
between activation of the coagulation cascade and the time at which the plasmin peak is 10 
reached. Plasmin peak height refers to the maximal plasmin generation rate. Fibrin lysis time 11 
refers to the time between the start of plasmin generation and the moment at which plasmin 12 
peak height is attained. In all instances, each plasma sample was analysed in duplicate and 13 
the average of each duplicate was used for further analysis. The inter-assay variation of 14 
thrombin generation parameters varies from 5.9% (AUCthrombin) to 25% (lag time thrombin 15 
generation). The inter-assay variation of plasmin generation parameters varies from 10% 16 
(plasmin peak height) to 14% (plasmin potential). 17 
For aim 2, we re-analysed the plasma samples at an assay temperature nearest to the 18 
subject’s CBT at baseline and finish in a subgroup of n=25. For example, if a subject had a 19 
baseline CBT of 37.4°C, the assay was performed at 37°C, whereas in case of a baseline 20 
CBT of ≥37.5°C and ≤38.4°C the assay was performed at 38°C. Likewise, a finish CBT of 21 
39.4°C was analysed at an assay temperature of 39°C and finish CBT ≥39.5°C at 40°C. Within 22 
this subgroup we also measured additional haemostatic parameters, in order to quantify the 23 
in vivo haemostatic activity. Plasma prothrombin fragment 1+2 was measured to assess the 24 
in vivo thrombin generation using an ezyme-linked immunosorbent assay (ELISA; Enzygnost 25 
F1+2, Behring Diagnostics GmbH, Frankfurt, Germany), while plasma D-dimer levels were 26 
measured to quantify the in vivo fibrinolysis activity using an ELISA (Zymutest D-dimer, 27 
Hyphen BioMed, Neuville-sur-Oise, France). Furthermore, we determined the isolated effect 28 
7 
 
of the assay temperature on haemostasis parameters by performing the analyses at 37°C, 1 
38°C, 39°C and 40°C in the subgroup of n=25. 2 
 3 
Statistical analyses were performed using the Statistical Package for the Social Sciences (IBM 4 
SPSS Statistics for Windows, Version 20.0, IBM Corp., Armonk, NY, USA). Data were 5 
reported as mean ± standard deviation unless otherwise indicated. All haemostasis data were 6 
visually inspected for normality distribution. In case of a non-Gaussian distribution, log-7 
transformation was performed and data were re-inspected. If a normal distribution could not 8 
be attained, non-parametric analyses were performed. The impact of exercise on changes in 9 
haemostatic parameters was assessed using a paired Student’s T-Test. To test the hypothesis 10 
that a higher finish CBT would aggravate the exercise-induced haemostatic responses two-11 
way repeated measurements analysis of variance (Gaussian distributed data) and Kruskal-12 
Wallis or Friedman test (non-Gaussian distributed data) were used. The relationship between 13 
finish CBT and post-exercise haemostasis parameters was calculated using a Pearson 14 
(Gaussian distributed data) or Spearman’s rank correlations (non-Gaussian distributed data).  15 
 16 
Results 17 
All subjects completed the race in cool environmental conditions (Wet bulb globe temperature 18 
12.5°C, Dry-Bulb temperature 10.5°C, relative humidity 87%, wind speed 3.4 – 5.4 m/s) at an 19 
average running speed of 12.1±1.8 km/h. The average body weight loss during the race was 20 
-1.4±0.6% of total body weight, and 18% of all subjects classified as dehydrated. Post-21 
exercise, lag time in thrombin generation (baseline 4.5±1.1 versus finish 3.8±0.7 min; p<0.001) 22 
and time to thrombin peak (9.0±1.4 vs. 8.0±0.9 min; p<0.001) were significantly shortened, 23 
whilst thrombin peak height (207±29 vs. 208±25 nmol/L; p=0.70) and AUCthrombin (1293±172 24 
vs. 1292±172 nmol/L/min; p=0.94) did not differ between baseline and post-exercise. Plasmin 25 
peak time (36.6±9.1 vs. 35.3±8.2 min; p=0.20) and fibrin lysis time (30.6±8.6 vs. 30.4±8.3 min; 26 
p=0.81) did not change after exercise, whereas a significant reduction in plasmin peak height 27 
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(19.2±12.2 vs. 10.0±9.0 nmol/L; Wilcoxon Signed Ranks Test p<0.001) was observed after 1 
finishing. 2 
 3 
Baseline CBT was 37.6±0.4°C and increased significantly (1.8±0.9°C, p<0.001) to 39.4±0.8°C 4 
at the finish line (range: 38.0–41.2°C). We identified 24 low-responders, 20 moderate-5 
responders and 18 high-responders for finish CBT. Coagulation and fibrinolysis responses did 6 
not differ across low-, moderate- and high-responders for all but one parameter (Table 1). A 7 
group effect (p<0.02) was found for AUCthrombin, with significantly higher values in moderate- 8 
and high-CBT responders compared to low-CBT responders. Similarly, the magnitude of 9 
ΔCBT did not interact with changes in haemostatic parameters (Supplemental Table 1). Lastly, 10 
neither finish-CBT nor ΔCBT correlated significantly with post-exercise haemostasis 11 
parameters, body weight loss or running speed (Supplemental Table 2). 12 
 13 
Synchronisation of the haemostatic assay temperature to actual baseline and finish CBT 14 
resulted in a significant decrease of lag time thrombin generation, time to thrombin peak, 15 
thrombin peak height and AUCthrombin between baseline and finish (Figure 1A-D respectively). 16 
Plasmin peak time synchronized to actual CBT and plasmin peak height decreased 17 
significantly between baseline and finish (Figure 1E + F), whilst fibrin lysis time did not change 18 
significantly (Figure 1G). Interestingly, a high finish CBT resulted in a prolonged fibrin lysis 19 
time, which was in contrast with subjects that reported a moderate and low finish CBT and 20 
demonstrated a shorter fibrin lysis time (Table 2). In addition, fragment 1+2 increased from 21 
223±121 pmol/L to 482±623 pmol/L (p<0.001), while d-dimer increased from 247±128 ng/L to 22 
1223±2821 ng/L (p<0.001). No correlation was found between the change in Fragment 1+2 23 
and finish CBT (r=-0.01; p=0.96) or the change in d-dimer and finish CBT (r=0.04; p=0.87). A 24 
similar effect of assay temperature on haemostasis parameters was observed in the subgroup 25 





The purpose of this study was to investigate whether the exercise-induced CBT-rise causes 2 
prothrombotic changes in a dose-dependent manner, and whether correcting the temperature 3 
at which the haemostasis assay is performed to approximate the subjects’ actual CBT alters 4 
the haemostasis outcomes. Our study demonstrates that thrombin generation peaked 5 
significantly earlier after the race compared to baseline and that plasmin peak height was 6 
significantly lower after finishing. However, changes in haemostatic parameters were not 7 
related to finish CBT or ΔCBT.  The novelty of our findings lies in the adjustment of the assay 8 
temperatures to approximate the subjects’ CBT. Correcting the assay temperature resulted in 9 
more pronounced changes of time to thrombin peak and AUCthrombin, and resulted in the 10 
additional identification of a significantly shortened lag time thrombin generation, decreased 11 
thrombin peak height and a significant impact of finish CBT on fibrin lysis time. These results 12 
suggest that increases in CBT may partially contribute to the exercise-induced haemostatic 13 
activation, but that (short lasting) exposure to CBTs up to 41.2°C does not result in clinical 14 
symptoms of increased coagulation. Hence, prolonged exposure or a higher CBT is needed 15 
to induce excessive coagulation that is typically observed in athletes diagnosed with 16 
heatstroke. Most importantly, our results demonstrate that synchronization of the temperature 17 
at which haemostasis assays are performed significantly influences the results. In situations 18 
where CBT is outside of normal (36.0 – 37.5°C) range, it is essential to adjust the assay 19 
temperature to obtain the most accurate results. 20 
 21 
Participants of our study demonstrated a large (1.8±0.9°C) and significant increase in CBT 22 
after running a 15 km road race, with an average finish CBT of 39.4±0.8°C. These 23 
thermoregulatory responses are in agreement with a previous study7. Our subjects were well 24 
trained (3.6±2.1 hrs/week) and were thus well accustomed to the elevated CBT caused by the 25 
exercise itself. We also observed a significant activation of the haemostatic balance, as 26 
expressed by a faster thrombin generation and an attenuated plasmin response. These 27 
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findings confirm the prothrombotic effects of exercise that were reported previously4 5 22. Since 1 
prolonged endurance training has previously been shown to attenuate the prothrombotic 2 
effects of exercise23, our findings might have been more pronounced in an untrained control 3 
group. Independent of training status, the combination of a large inter-individual variation in 4 
CBT with a significant haemostatic activation allows us to explore the potential relationship 5 
between these exercise-induced phenomena. 6 
 7 
Haemostatic responses were largely comparable between low, moderate and high responders 8 
of finish CBT. Although the AUCthrombin was significantly higher in moderate- and high-9 
responders compared to low-responders, the other exercise-induced haemostatic changes 10 
did not differ across finish-CBT groups. In contrast to our hypothesis, these data suggest that 11 
the exercise-induced pro-thrombotic changes do not depend on finish CBT. The observation 12 
of a massive haemostatic activation in patients with heatstroke suggests that excessive 13 
thrombotic responses may only occur above a certain CBT threshold or after prolonged 14 
exposure to a high CBT24 25. Hence, the peak finish CBT that was reported in our study 15 
(41.2°C) was apparently either too low to induce substantial activation of the coagulation 16 
cascade, or too short lasting to induce substantial changes. Data from several animal studies 17 
reinforced this hypothesis and showed that prolonged (2.5 - 3 hours) passive heating with a 18 
CBT >42°C was needed to induce excessive activation of the haemostatic response11 26 27. 19 
Indeed, the finish CBTs that were observed in our subjects did not result in a derailed 20 
haemostatic response nor in clinical symptoms. This was supported by the statistically 21 
significant, though clinically irrelevant, increase in plasma prothrombin fragment 1+2 and d-22 
dimer levels in absence of a correlation of these parameters with finish CBT. Therefore, 23 
physical exercise typically performed by the general population does not necessarily result in 24 
a derailment of blood haemostasis. 25 
 26 
Importantly, the absence of an interaction between CBT and haemostasis may relate to the 27 
fact that analyses were performed at 37°C instead of the actual CBT at the time of blood 28 
11 
 
collection. When synchronizing the assay temperature to the individual’s baseline and finish 1 
CBT, we observed additional and stronger baseline-to-finish changes in several haemostatic 2 
parameters compared to the findings from the assay at 37°C (Figure 1). Differences were not 3 
limited to finish results, but also showed altered baseline values when synchronizing for 4 
baseline CBT. Athletes with a finish CBT ≥40.0°C demonstrated a significantly larger fibrin 5 
lysis time compared to peers with a lower finish CBT who demonstrated a reduced fibrin lysis 6 
time. These findings were confirmed by the analysis in which we varied the assay temperature 7 
(Supplemental Table 3) and suggest a direct impact of CBT on exercise-induced haemostatic 8 
responses. Interestingly, we have observed this effect after analysis of frozen plasma samples 9 
which had already been exposed once in vivo to an elevated temperature during the exercise 10 
bout. The fact that we were able to identify additional significant changes or stronger baseline-11 
to-finish changes compared to when the assays were performed routinely at 37°C suggests 12 
that at least part of the observed procoagulant effects are temperature-dependent. Evidence 13 
from previous studies in hypothermic patients support our observations. These studies 14 
showed that lowering the haemostatic assay temperature to mimic the real-life CBT resulted 15 
in a prolonged initiation of blood clotting, whilst the absolute concentration of clotting factors 16 
remained unchanged15 28 29. Altogether, these data suggest that altering the CBT causes the 17 
enzymatic coagulation reaction to become slower at lower temperatures versus faster at 18 
higher temperatures29. Our findings therefore demonstrate that it is essential to adjust the 19 
assay temperature to approximate the subject’s CBT in order to obtain the most accurate 20 
results. This may not only apply to exercise-induced CBT rises, but also to other conditions 21 
where CBT is outside of the normal physiological range. 22 
 23 
We found that running a 15 km road race resulted in a pro-coagulant state, which is partially 24 
dependent on the magnitude of the exercise-induced rise in CBT. None of our subjects 25 
experienced clinical coagulation-related problems, which indicates that changes in 26 
haemostatic parameters that are accompanied by a CBT up to 41.2°C are of minor clinical 27 
relevance. Hence, our data suggest that heatstroke-induced disseminated intravascular 28 
12 
 
coagulation, which is a serious threat for endurance athletes30, occurs when CBT passes a 1 
certain threshold value. Once an athlete exceeds this threshold and is diagnosed with 2 
heatstroke, our data underline the importance of rapid and aggressive cooling, which may 3 
reduce the CBT related stimulation of the coagulation cascade and could result in a better 4 
outcome. Notably, given the diverse range of peak core body temperatures that individuals 5 
develop during exercise7, this CBT threshold might be individually determined. 6 
 7 
A potential limitation of the present study is that blood samples were collected within 5 minutes 8 
after finishing, while CBT was assessed directly at the finish line. Due to the time difference, 9 
subjects may have had a slightly lower CBT at the time of blood collection due to passive 10 
cooling. Nevertheless, it is unlikely that these minor CBT differences would impacted our 11 
haemostasis results, apart from the fact that it would even underestimate our findings. Another 12 
potential limitation of the present study is that we did not correct for exercise-induced changes 13 
in plasma volume. However, 82% of our study population was well hydrated, making it unlikely 14 
that shifts in plasma volume had a large impact on study outcomes. Importantly, all 15 
measurements for the temperature adjusted assays were performed on the same plasma 16 
samples and the only manipulated factor was assay temperature. Therefore, the adjusted 17 
assay temperature data were not affected by plasma volume changes. Lastly, whilst the 18 
applied haemostasis assay has a low inter-assay variability for analyses performed on a single 19 
say, the variability is slightly larger when comparing analyses performed on separate days (for 20 
example Table 1 versus Supplemental Table 3). All results reported within each table were 21 
therefore acquired on a single day and all reported results can thus be safely interpreted within 22 
each table. However, even though the assay variability when performed on separate days was 23 
limited, caution should be applied when comparing several tables with one another. 24 
 25 




In conclusion, this study demonstrates that exercise induces a procoagulant state, and our 2 
results suggest that this might partially be dependent on the magnitude of the exercise-3 
induced CBT rise. Moreover, athletes with a finish CBT as high as 41.2°C do not necessarily 4 
demonstrate haemostatic activation leading to clinical symptoms. We therefore hypothesize 5 
that prolonged exposure to, or a specific CBT threshold needs to be exceeded before 6 
derailment of the haemostatic balance occurs. Most importantly, our results show that 7 
adjusting the assay temperature to approximate the subject’s CBT is highly recommended to 8 
obtain more accurate insight in the haemostatic balance when CBT lies outside the 9 
physiological range. 10 
 11 
Practical implications 12 
• 15-km running exercise resulted in a significant increase of core body temperature to 13 
39.4±0.8°C, and significant procoagulant haemostasis activity by increasing thrombin 14 
generation and attenuating plasmin responses. 15 
• Whilst haemostatic responses were comparable between individuals with a low or 16 
high finish core body temperature, adjusting the assay temperature to approximate 17 
the individual’s actual core body temperature revealed a significant interaction 18 
between core body temperature and fibrinolytic activity. 19 
• These findings suggest that the prothrombotic state induced by exercise might be 20 
partially dependent on the exercise-induced core body temperature rise. Adjusting 21 
the assay temperature to approximate the individual’s actual core body temperature 22 
is essential to obtain the most accurate results when body temperature is outside the 23 
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Figure 1:  Results of the routinely performed assays (left hand side of graph) versus the assay 
results corrected for the actual core body temperature (right hand side of graph) at baseline 
and post-finish (black and grey bars respectively). All corrected results for the baseline 
samples were corrected for CBT at baseline, and all corrected results for the finish samples 
were corrected for CBT at the finish line. (A) Lag Time Thrombin Generation; (B) Time to 
Thrombin Peak; (C) Thrombin Peak Height; (D) AUCthrombin; (E) Plasmin Peak Time; (F) 
Plasmin Peak Height; (G) Fibrin Lysis Time. Legend: # = p<0.05; † = p<0.01; ‡ = p<0.001; * = 
Statistics are based on non-parametric analysis. Data are presented as mean ± standard error 






Supplemental Figure 1: Schematic overview of the Nijmegen Haemostasis Assay. The dotted 
line represents real-time measurement of thrombin generation, whilst the continuous line 
represents the simultaneous real-time measurement of plasmin generation in the same blood 
sample. For the purposes of the present study, four parameters were derived from thrombin 
generation: (1) Lag Time Thrombin Generation (min), (2) Time to Thrombin Peak (min), (3) 
Thrombin Peak Height (nmol/L) and (4) AUCthrombin (nmol/L/min). From plasmin generation, 
three parameters were derived: (5) Plasmin Peak Time (min), (6) Plasmin Peak Height (nmol/L) 
and (7) Fibrin lysis time (min). Adapted from Van Geffen et al. (2011).21 
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